Skip to content

Join Us for a Conversation on the Business of Longevity – The New York Times

Billions of dollars are being invested in the idea of immortality — or, at least, living much longer than we do today.

Where is the money going in this fast-growing field? What are the realities of altering the aging process? What are the larger implications of extending life for society, business and the environment? On Oct. 12 at 1 p.m. Eastern time, join Andrew Ross Sorkin and DealBook reporter Lauren Hirsch to discuss these questions and more with the leading Harvard researcher and biotech company founder David Sinclair.

This is the second installment of our new DealBook Dialogue virtual series. Submit your questions when you R.S.V.P., or live during the event.

We’re looking forward to hearing your thoughts and seeing you there.